EUVIMEDEUVIMED entdecken
Crossref

Targeting GALNT4 suppresses atherosclerosis via TNFR1/NF-κB mediated attenuation of endothelial inflammation

Pengcheng Wei, Duan Li, Wenxuan Chen, Xiaoxuan Zhang, Wang Xinru, Zhao Han, Yikai Wang, Liwei Guo

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2025.112209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Pengcheng Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Forensic Medicine, Xinxiang Medical University, Xinxiang, Henan, China. Hauptthemen laut MEDLINE: N-Acetylgalactosaminyltransferases, Atherosclerosis, NF-kappa B, Inflammation. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Key Scientific Research Project of Colleges and Universities in Henan Province, Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial inflammation is a critical driver of atherosclerosis (AS). Although N-acetylgalactosaminyltransferase 4 (GALNT4) has been genetically linked to coronary artery disease, its specific function and mechanism within endothelial cells (ECs) during AS progression remain poorly understood, presenting a significant knowledge gap. This study aimed to elucidate the precise role of GALNT4 in endothelial inflammation and AS development. GALNT4 expression was assessed in human and mouse atherosclerotic plaques. ApoE-/- mice fed on a high-fat diet (HFD) received AAV-shRNA-mediated GALNT4 knockdown to evaluate atherosclerotic lesions and vascular inflammation. In vitro, gain and loss-of-function studies were conducted in TNF-α-treated human umbilical vein endothelial cells (HUVECs) to investigate monocyte adhesion and NF-κB activation. Mechanistic insights were gained through lectin blot, co-immunoprecipitation, and chromatin immunoprecipitation (ChIP) assays. Results showed that GALNT4 expression was significantly upregulated in human and mouse atherosclerotic plaques. In ApoE-/- mice, GALNT4 knockdown markedly attenuated atherosclerotic lesion area (45.1 % reduction) and reduced ICAM-1/VCAM-1 expression without altering plasma lipids. In HUVECs, TNF-α induced GALNT4 expression in a dose and time-dependent manner. Functionally, GALNT4 knockdown suppressed TNF-α-induced monocyte adhesion, while its overexpression exacerbated these effects. Mechanistically, GALNT4 knockdown reduced O-GalNAcylation of TNFR1, diminished TNF-α-triggered phosphorylation and nuclear translocation of NF-κB p65, and inhibited NF-κB binding to the ICAM-1 and VCAM-1 promoters. Our findings demonstrate that GALNT4, upregulated in AS, promotes endothelial inflammation by enhancing the O-GalNAcylation of TNFR1 and subsequent activation of the NF-κB pathway. Targeting GALNT4 represents a promising therapeutic strategy for attenuating AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-AcetylgalactosaminyltransferasesAtherosclerosisNF-kappa BInflammationReceptors, Tumor Necrosis Factor, Type IAnimalsHumansPolypeptide N-acetylgalactosaminyltransferaseHuman Umbilical Vein Endothelial CellsMiceMaleMice, Inbred C57BLPlaque, AtheroscleroticSignal TransductionTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

AtherosclerosisEndothelial inflammationGALNT4TNFR1/NF-κB pathway

Substanzen

N-AcetylgalactosaminyltransferasesPolypeptide N-acetylgalactosaminyltransferaseNF-kappa BReceptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • School of Forensic Medicine, Xinxiang Medical University, Xinxiang, Henan, China.
  • School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan, China.
  • Junji Academy, Xinxiang Medical University, Xinxiang, Henan, China.
  • The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, China.
  • School of Forensic Medicine, Xinxiang Medical University, Xinxiang, Henan, China. Electronic address: 071012@xxmu.edu.cn.

Förderung

  • Key Scientific Research Project of Colleges and Universities in Henan Province
  • Natural Science Foundation of Henan Province

Zitieren

APA

Wei, P., Li, D., Chen, W., Zhang, X., Xinru, W., Han, Z., Wang, Y., & Guo, L. (2026). Targeting GALNT4 suppresses atherosclerosis via TNFR1/NF-κB mediated attenuation of endothelial inflammation. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112209

Vancouver

Wei P, Li D, Chen W, Zhang X, Xinru W, Han Z, et al. Targeting GALNT4 suppresses atherosclerosis via TNFR1/NF-κB mediated attenuation of endothelial inflammation. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112209

BibTeX
@article{Wei2026,
  author = {Wei, Pengcheng and Li, Duan and Chen, Wenxuan and Zhang, Xiaoxuan and Xinru, Wang and Han, Zhao and Wang, Yikai and Guo, Liwei},
  title = {Targeting GALNT4 suppresses atherosclerosis via TNFR1/NF-κB mediated attenuation of endothelial inflammation},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2025.112209}
}
Kostenlos starten →